US05961W1053 - ADR

**BMA** gets a fundamental rating of **4** out of 10. The analysis compared the fundamentals against 405 industry peers in the **Banks** industry. Both the profitability and financial health of **BMA** have multiple concerns. **BMA** is valued quite expensively, but it does show have an excellent growth rating.

In the past 5 years **BMA** has always been profitable.

In multiple years **BMA** reported negative operating cash flow during the last 5 years.

Looking at the **Return On Assets**, with a value of **5.16%**, **BMA** belongs to the top of the industry, outperforming **99.75%** of the companies in the same industry.

With an excellent **Return On Equity** value of **18.93%**, **BMA** belongs to the best of the industry, outperforming **97.01%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.16% | ||

ROE | 18.93% | ||

ROIC | N/A |

ROA(3y)4.51%

ROA(5y)4.21%

ROE(3y)16.17%

ROE(5y)16.7%

ROIC(3y)N/A

ROIC(5y)N/A

The **Profit Margin** of **BMA** (**12.84%**) is worse than **78.86%** of its industry peers.

In the last couple of years the **Profit Margin** of **BMA** has declined.

The **Operating Margin** and **Gross Margin** are not available for **BMA** so they could not be analyzed.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | 12.84% | ||

GM | N/A |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y5.35%

PM growth 5Y-6.18%

GM growth 3YN/A

GM growth 5YN/A

The number of shares outstanding for **BMA** remains at a similar level compared to 1 year ago.

Compared to 5 years ago, **BMA** has less shares outstanding

The debt/assets ratio for **BMA** is higher compared to a year ago.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.14 | ||

Debt/FCF | N/A | ||

Altman-Z | N/A |

ROIC/WACCN/A

WACCN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | N/A | ||

Quick Ratio | N/A |

The **Revenue** has grown by **296.55%** in the past year. This is a very strong growth!

The **Revenue** has been growing by **119.85%** on average over the past years. This is a very strong growth!

EPS 1Y (TTM)415.48%

EPS 3Y170.06%

EPS 5Y102.57%

EPS Q2Q%-408.36%

Revenue 1Y (TTM)296.55%

Revenue growth 3Y139.02%

Revenue growth 5Y119.85%

Sales Q2Q%-24.94%

The **Revenue** is expected to grow by **65.50%** on average over the next years. This is a very strong growth

EPS Next Y37.69%

EPS Next 2Y9.71%

EPS Next 3Y28.7%

EPS Next 5YN/A

Revenue Next Year311.2%

Revenue Next 2Y70.77%

Revenue Next 3Y65.5%

Revenue Next 5YN/A

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | N/A |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y9.71%

EPS Next 3Y28.7%

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**BANCO MACRO SA-ADR**

NYSE:BMA (10/14/2024, 8:16:34 PM)

Premarket: 74.5 +0.32 (+0.43%)**74.18**

**-0.65 (-0.87%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap4.74B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.16% | ||

ROE | 18.93% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | N/A | ||

PM (TTM) | 12.84% | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.4

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.14 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | N/A | ||

Quick Ratio | N/A | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)415.48%

EPS 3Y170.06%

EPS 5Y

EPS Q2Q%

EPS Next Y37.69%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)296.55%

Revenue growth 3Y139.02%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y